FindTrial
Sign In

Clinical and Endoscopic Evaluation of Patients Presenting with Acute Upper Gastrointestinal Bleeding

Study of clinical and endoscopic profile of patients with acute upper GI bleed - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080193
Enrollment
100
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K920- Hematemesis

Interventions

Control Intervention1: Nil: nil

Sponsors

DrSourab Arora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: adults aged 18 and above. 2. Acute upper GI bleed: Patients presenting with signs and symptoms of acute upper GI bleeding, which may include hematemesis (vomiting of blood), melena (dark, tarry stools), or hematochezia (passage of fresh blood through the rectum). 3. Confirmed diagnosis: Patients with a confirmed diagnosis of acute upper GI bleeding based on clinical evaluation and diagnostic tests. 4. Endoscopy: Patients who have undergone upper GI endoscopy as part of their diagnostic evaluation.

Exclusion criteria

Exclusion criteria: Chronic GI bleeding: Patients with chronic or recurrent GI bleeding rather than acute bleeding. 2. Non-upper GI bleed: Patients with lower GI bleeding (e.g., colonic or rectal bleeding) rather than upper GI bleeding. 3. Known bleeding disorders: Patients with known bleeding disorders or coagulopathies that may affect the presentation or management of acute upper GI bleeding. 4. Previous upper GI surgery: Patients who have undergone previous upper GI surgery, as this may affect the endoscopic findings or clinical profile.

Design outcomes

Primary

MeasureTime frame
1. To determine the frequency and distribution of different etiologies of acute UGIB. 2. To assess the presenting symptoms and signs of acute UGIB. 3. To determine the severity of acute UGIB using clinical and laboratory parameters. 4. To describe the endoscopic findings in patients with acute UGIB. 5. To assess the outcomes of patients with acute UGIB, including rebleeding, need for transfusion, need for endoscopic or surgical intervention, length of hospital stay, and mortality. Timepoint: Baseline 1 year—

Secondary

MeasureTime frame
1-Two month follow-up recurrenceTimepoint: Baseline 1 year—

Countries

India

Contacts

Public ContactDr Sourab Arora

DY PATIL hospital,Navi Mumbai

Shettyvarun81@gmail.com9833991811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026